好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Induction of a CD4+CD25+ T Cell Subset Following Blockade of CD154 in a Phase I Clinical Trial in RRMS
MS and Related Diseases
(-)
005
Authors/Disclosures
Lloyd H. Kasper, MD (Dartmouth Medical School) No disclosure on file
Maria J. Bruzzone, MD (University of Florida) Dr. Bruzzone has nothing to disclose.
Jacqueline Channon-Smith (Dartmouth Medical School) No disclosure on file
Naoum P. Issa, MD, PhD (University of Chicago) Dr. Issa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CVS. Dr. Issa has received stock or an ownership interest from Gilead. The institution of Dr. Issa has received research support from NIH.
Camilo E. Fadul, MD, FAAN (University of Virginia Health System) No disclosure on file
Anila Thomas, MD Dr. Thomas has nothing to disclose.
James X. Tao, MD, PhD Dr. Tao has nothing to disclose.
No disclosure on file
Sandra Rose, MD No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
Shasha Wu, MD, PhD (University of Chicago) No disclosure on file